Meprin A activators are a category of compounds that increase the enzymatic activity of Meprin A, a zinc-dependent metalloprotease involved in the proteolytic processing of various substrates. The search for Meprin A activators typically begins with an assay development phase in which a robust and reliable assay capable of quantifying Meprin A activity is established. One common approach is to use a fluorogenic peptide substrate that releases a fluorescent signal upon cleavage by Meprin A. This assay format is amenable to high-throughput screening (HTS), allowing researchers to test large libraries of chemical compounds for their ability to enhance the enzymatic activity of Meprin A. Compounds that result in an increased fluorescent signal are identified as primary hits. These initial hits are then subjected to a battery of secondary confirmatory tests to eliminate false positives and to verify their specific activity towards Meprin A.
Following the identification of initial hits, the next step involves a more detailed analysis of the interaction between the activators and Meprin A. Techniques such as surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) can be utilized to study the binding affinity and kinetics of the activator-Meprin A interaction. These methods provide insights into the strength and stability of the complex formed between the activator and the enzyme, which are crucial parameters in understanding how the activators increase Meprin A activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
Batimastat is a broad-spectrum metalloprotease inhibitor that can paradoxically lead to the enhanced activity of Meprin A by preventing the degradation of its substrates. This would allow more substrate availability for Meprin A to act upon, thereby increasing its functional proteolytic activity. | ||||||
Actinonin | 13434-13-4 | sc-201289 sc-201289B | 5 mg 10 mg | $170.00 $385.00 | 3 | |
Actinonin is a peptide antibiotic that inhibits aminopeptidases, which can lead to an accumulation of peptide substrates in the extracellular matrix, indirectly enhancing the proteolytic role of Meprin A by providing more substrates for its action. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a protease inhibitor that can increase the substrate availability for Meprin A by inhibiting serine proteases, which are responsible for degrading protein substrates that Meprin A could otherwise process. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Marimastat is a matrix metalloprotease inhibitor that can lead to enhanced activity of Meprin A by allowing more extracellular matrix components to be available as substrates, as it would reduce the competition for these substrates. | ||||||
TAPI-2 | 187034-31-7 | sc-205851 sc-205851A | 1 mg 5 mg | $286.00 $1019.00 | 15 | |
TAPI-0 is an inhibitor of ADAMs (A Disintegrin And Metalloprotease), which can lead to increased substrate availability for Meprin A in the extracellular space, thereby indirectly enhancing its proteolytic function. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
Captopril is an angiotensin-converting enzyme (ACE) inhibitor that could lead to increased levels of peptides in the extracellular matrix, which may indirectly increase the proteolytic activity of Meprin A by providing more substrates. | ||||||